Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-severe Pain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03617536
What this trial is testing

Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 269
Not applicableUnknownNCT03574636
What this trial is testing

OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Who this might be right for
Optical Coherence TomographyIntravascular UltrasoundAngiography
Shanghai MicroPort Medical (Group) Co., Ltd. 375
Large-scale testing (Phase 3)Study completedNCT01082471
What this trial is testing

An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours

Who this might be right for
Postoperative Pain
Paion UK Ltd. 517
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Not applicableStudy completedNCT03112512
What this trial is testing

A Comparison of Optimal PEEP Determination Guided by EIT and G5 Device in Moderate and Severe ARDS Patients

Who this might be right for
Acute Respiratory Distress Syndrome
Mei-Yun Chang 88
Testing effectiveness (Phase 2)Looking for participantsNCT06912165
What this trial is testing

WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Brief Description of Focus of Study
Zhejiang Wenda Pharma Technology LTD. 140
Not applicableStudy completedNCT01891630
What this trial is testing

Observational Assessment of Baseline Asthma Control in African-American Children

Who this might be right for
Asthma
University of North Carolina, Chapel Hill 25
Large-scale testing (Phase 3)Study completedNCT03946592
What this trial is testing

Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

Who this might be right for
Submental Fat
Daewoong Pharmaceutical Co. LTD. 148
Large-scale testing (Phase 3)Study completedNCT05463965
What this trial is testing

Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Galderma R&D 605
Testing effectiveness (Phase 2)Study completedNCT02933502
What this trial is testing

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 3
Post-approval studies (Phase 4)Study completedNCT01331837
What this trial is testing

Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 3,080
Large-scale testing (Phase 3)Study completedNCT01655381
What this trial is testing

A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 15
Testing effectiveness (Phase 2)Ended earlyNCT03345407
What this trial is testing

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 943
Not applicableUnknownNCT03397901
What this trial is testing

Transverse Colostomy for Refractory Hemorrhagic Chronic Radiation Proctitis: a Prospective Cohort Study

Who this might be right for
Chronic Radiation ProctitisRectal BleedingColostomy Stoma+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 50
Not applicableUnknownNCT03082508
What this trial is testing

A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure

Who this might be right for
Heart FailureDilated CardiomyopathyHeart Failure With Reduced Ejection Fraction
LoneStar Heart, Inc. 240
Not applicableStudy completedNCT04257370
What this trial is testing

Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations

Who this might be right for
Diabetic Foot UlcerDehiscence of Amputation StumpAmputation
Kerecis Ltd. 260
Testing effectiveness (Phase 2)UnknownNCT05947812
What this trial is testing

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Who this might be right for
COVID 19 DiseaseMild to Moderate COVID 19 DiseaseSARS-CoV-2+2 more
60P Australia Pty Ltd 148
Not applicableStudy completedNCT01435265
What this trial is testing

Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab

Who this might be right for
Psoriasis
Wake Forest University Health Sciences 7
Not applicableStudy completedNCT00930592
What this trial is testing

Peds Metabolic Syndrome in Psoriasis

Who this might be right for
PsoriasisMetabolic Syndrome
Tufts Medical Center 42
Large-scale testing (Phase 3)Study completedNCT00658775
What this trial is testing

Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Eisai Inc. 1,069
Next Page